Triprolidine

DEA Class; OTC

Common Brand Names; Histex, Vanahist PD, Histex PD Drops, M-Hist PD, Vanaclear PD

  • Antihistamines, 1st Generation

First generation histamine-1 receptor antagonist

Indicated for temporary relief of rhinorrhea, sneezing, itchy nose, throat, or eyes owing to have fever or other upper respiratory allergies or allergic rhinitis

Patients taking sedatives or tranquilizers

Hypersensitivity; note that cross allergenicity may occur between chemically similar antihistamines

  • Blurred vision
  • Sedation
  • Urinary retention
  • Constipation
  • Xerostomia

May cause CNS depression, resulting in impaired physical or mental abilities; caution patients about performing tasks that require mental alertness (eg, driving, operating machinery)

Antihistamines may cause excitation in young children

Discontinue and contact physician if symptoms persist beyond 7 days or are accompanied by fever

Discontinue and contact physician if nervousness, dizziness, or sleeplessness occur

Do not exceed recommended dose

Discontinue therapy and ask doctor if new symptoms occur

Ask a healthcare professional before self-medication if experiencing breathing problems such as emphysema or chronic bronchitis, glaucoma, enlarged prostate (difficulty urinating)

Pregnancy

Limited data exist

Generally, antihistamines are considered low risk during pregnancy; however, exposure near birth of premature infants was associated with increased risk of retrolental fibroplasia

Lactation

Distributed in human breast milk; small, occasional doses are not expected to cause adverse effects in infant

Histex: 2.5 mg (5 mL) PO q6hr

Vanahist PD or M-Hist PD: 2.5 mg (4 mL) PO q6hr

Triprolidine

oral liquid

  • 0.5mg/mL (Histex)
  • 0.625mg/mL (Vanahist PD, M-Hist PD)

About the Author

You may also like these

0